Tactile Systems Technology Inc (TCMD) is not a strong buy at the moment for a beginner investor with a long-term strategy. Despite strong financial performance and positive analyst ratings, the stock is currently in a downtrend, with technical indicators showing oversold conditions and insider selling activity increasing significantly. The lack of recent news, no proprietary trading signals, and neutral hedge fund sentiment further suggest waiting for a more favorable entry point.
The stock is in a downtrend with a regular market change of -5.28%. The MACD is negative and expanding, RSI indicates oversold conditions at 17.135, and moving averages are converging. The stock is trading near its support level (S1: 24.726) but below the pivot point (26.071).

Strong Q4 financial performance with revenue up 21.04% YoY, net income up 9.45% YoY, and EPS up 15.00% YoY. Analysts have raised price targets significantly, with multiple firms maintaining Buy or Overweight ratings. The company's lymphedema business shows strong growth potential.
Insider selling has increased by 867.75% in the last month, indicating potential lack of confidence from insiders. No recent news or events to drive positive sentiment. Hedge funds are neutral, and there is no recent congress trading data. The stock's technical indicators suggest continued downward pressure in the short term.
In Q4 2025, Tactile Systems reported revenue growth of 21.04% YoY to $103.59M, net income growth of 9.45% YoY to $10.63M, and EPS growth of 15.00% YoY to $0.46. Gross margin improved to 77.62%, up 4.23% YoY.
Analysts have raised price targets significantly, with targets ranging from $32 to $42. Most analysts maintain Buy or Overweight ratings, citing strong Q4 performance, growth in the lymphedema business, and positive FY26 guidance. However, one analyst remains Neutral, citing limited upside from current levels.